cancer-therapy

Documents about cancer-therapy

• Lu-177-[DOTA0,Tyr3] Octreotate Therapy in Patients With Disseminated Neuroendocrine Tumors: Analysis of Dosimetry With Impact on Future Therapeutic Strategy#178006Lund University Publications
• Additional file 1 of Annual dialysis data report 2023, Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry#658821Figshare
• Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial#160371ClinicalTrials.gov
• Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy#4574Europe PMC
• Systematic skin cancer screening in patients treated with biologics for chronic inflammatory rheumatic diseases: an 11-year experience#147438HAL (France)
• Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications#202784IRIS
• Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort#284519IRIS
• A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.#314330ClinicalTrials.gov
• A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse#800644ClinicalTrials.gov
• IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer#67683ClinicalTrials.gov
• Real-world EHR-derived progression-free survival across successive lines of therapy informs metastatic breast cancer risk stratification#133208bioRxiv / medRxiv
• Study on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients#157997ClinicalTrials.gov
• Heterogeneous Sensitivity to Src Inhibitors in Oral Squamous Cell Carcinoma and Its Implications for Combination Therapy with Cisplatin#162263bioRxiv / medRxiv
• Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors#162546ClinicalTrials.gov
• Multicomponent Prehabilitation and Outcomes in Elderly Patients With Frailty#172479ClinicalTrials.gov
• Practical guidance for echocardiography for cancer therapy-related cardiac dysfunction: 2026 focused update#243149Springer Nature OA
• Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer#287524ClinicalTrials.gov
• CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy#307456ClinicalTrials.gov
• Disseminated Tuberculosis Mimicking Metastatic Cancer During Ruxolitinib Therapy for Polycythemia Vera: A Case Report and Literature Review.#308825NCBI PubMed Central
• Vaccine Therapy in Treating Patients With Multiple Myeloma#314388ClinicalTrials.gov
• MRI-Based Radiomics to Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Retrospective Study.#315505NCBI PubMed Central
• Magnetic Fields in Cancer Therapy: Mechanistic Insights, Signaling Pathways, and Evidence from Clinical and In Vitro Studies.#317881NCBI PubMed Central
• Adjuvant Radiation Therapy in Macroscopic Regional Nodal Melanoma#336298ResearchOnline@ND
• Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma#349941ClinicalTrials.gov
• Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma#356119Zenodo (CERN)
• A Feasibility Study of Reiki Therapy to Improve Symptoms in Cancer Survivors at an Integrative Oncology Clinic.#362044NCBI PubMed Central
• Association of Psychological Distress in Patients With Lung Cancer#363624ClinicalTrials.gov
• Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.#407737ClinicalTrials.gov
• Integrative profiling of diverse post-translational modifications for prognostic stratification and personalized therapy in papillary thyroid cancer.#446124NCBI PubMed Central
• Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma#474760ClinicalTrials.gov
• Systematic adaptation of ProSleep for men initiating androgen-deprivation therapy for prostate cancer: development of ProSleep-Pro#637557OSF
• A promising combination strategy: oncolytic adenovirus (ΔE1B-55 K/E3) and arsenic trioxide for potent cancer therapy.#659811NCBI PubMed Central
• Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.#662704NCBI PubMed Central
• Profiling neoadjuvant therapy response in rectal cancer using meta-analysis of publicly available transcriptomic RNA-seq datasets.#670988NCBI PubMed Central
• Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma#674900ClinicalTrials.gov
• Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative#148766ClinicalTrials.gov
• First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy#172301ClinicalTrials.gov
• PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy#184828ClinicalTrials.gov
• Linker Optimization in Lu-177 Labeled αvβ6-Integrin Binding Peptide Trimers for Targeted Radionuclide Therapy of Cancer#229635Figshare
• Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)#230397ClinicalTrials.gov
• TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy#314343ClinicalTrials.gov
• Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy#471444ClinicalTrials.gov
• Table 1_The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development.docx#471743Figshare
• Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial#460103ClinicalTrials.gov
• Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma#127612ClinicalTrials.gov
• Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)#146457ClinicalTrials.gov
• Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma#28320ClinicalTrials.gov
• From Acoustic Analog of Space, Cancer Therapy, to Acoustic Sachs-Wolfe Theorem: A Model of the Universe as a Guitar#118307PhilArchive
• Digital art therapy for emotional well-being in adults with cancer: A scoping review of digital health interventions.#120047NCBI PubMed Central
• The inhibitory effect of hepatic cancer energy metabolism on immune checkpoint therapy: perspectives from single-cell multi-omics analysis.#143246NCBI PubMed Central